Skip to main content
Anixa Biosciences Inc logo

Anixa Biosciences Inc — Investor Relations & Filings

Ticker · ANIX ISIN · US45069V2034 LEI · 549300PW2C2QTAJL2D19 US Professional, scientific and technical activities
Open in API
Filings indexed 958 across all filing types
Latest filing 2015-03-09 Interim / Quarterly Rep…
Country US United States of America
Listing US ANIX

About Anixa Biosciences Inc

https://www.anixa.com/

Anixa Biosciences Inc. is a clinical-stage biotechnology company focused on developing therapies and vaccines for the treatment and prevention of cancer. The company's portfolio is centered on two main platforms: a therapeutics program and a vaccine program. The therapeutics portfolio features a Chimeric Antigen Receptor T-cell (CAR-T) immunotherapy, which genetically engineers a patient's own immune cells to target and destroy solid tumors. The vaccine portfolio includes preventative and therapeutic candidates for various cancers, with a primary focus on breast and ovarian cancer, and discovery programs for lung, colon, and prostate cancer. Anixa aims to address critical unmet needs in oncology through these innovative approaches.

Recent filings

Filing Released Lang Actions
FORM 10-Q
Interim / Quarterly Report Q1 2015
2015-03-09 English
POS AM
Capital/Financing Update Classification · 95% confidence The document is a Post-Effective Amendment No. 2 to Form S-3 on Form S-1 Registration Statement filed with the SEC. It includes detailed information about securities registration, resale of shares, and primary issuance of shares. The document references the Securities Act of 1933 and registration fees, and it is clearly a regulatory filing related to capital raising and securities registration. It is not a financial report, earnings release, or management discussion. It is a formal SEC filing for registration of securities, which fits the Capital/Financing Update (CAP) category as it relates to fundraising and capital structure changes.
2015-03-03 English
Regulatory Filings 2015
Regulatory Filings Classification · 95% confidence The document is a correspondence letter from ITUS Corporation to the SEC responding to comments on a Registration Statement on Form S-1 filed previously. It discusses updates to include audited financial statements for the fiscal year ended October 31, 2014, but does not itself contain financial statements or a full report. The letter is a regulatory communication related to a registration filing, not a financial report or announcement of voting results, management changes, or other categories. It is a regulatory filing correspondence responding to SEC staff comments, which fits best under Regulatory Filings (RNS). The document length is short and it is clearly a letter, not a report or announcement of a report publication.
2015-03-03 English
FORM S-1/A
Capital/Financing Update Classification · 100% confidence The document is a Form S-1/A, which is an amendment to a registration statement filed with the SEC under the Securities Act of 1933. It is related to the registration of securities for resale by a selling stockholder and includes detailed information about the securities, the offering, and the company. This type of filing is a capital markets document used for initial public offerings or secondary offerings, not a financial report, earnings release, or management discussion. It is not an announcement or a proxy statement but a formal registration statement amendment. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length and content confirm it is the actual filing, not just an announcement or certification.
2015-03-03 English
FORM S-8
Capital/Financing Update Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used to register securities to be offered under employee benefit plans such as stock incentive plans and stock option agreements. It includes detailed information about the number of shares to be registered, the plans under which they are issued, and related prospectus information. This type of filing is a capital/financing update related to the company's equity compensation plans and stock option agreements, not a financial report or earnings release. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is a full registration statement, not a brief announcement or certification.
2015-03-03 English
SC 13D
Major Shareholding Notification
2015-02-20 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.